Prenatal Poly I:C exposure affects tryptophan-kynurenine metabolism associated with intestinal microbiome in female

Lirong Yang1,2, Huiyu Chen2,3, Menglu Zeng2,3

  • 1School of Public Health, Fujian Medical University, Fuzhou, China.

Frontiers in Immunology
|October 17, 2025
PubMed

Insights

Maternal inflammation during pregnancy disrupts tryptophan metabolism and gut bacteria, leading to neurodevelopmental issues and behavioral problems in offspring. This highlights the gut-microbiota-tryptophan axis as a critical factor in these impairments.

Area of Science:

  • Neuroscience
  • Microbiology
  • Developmental Biology

Background:

  • Disrupted tryptophan (TRP) metabolism is increasingly linked to neurodevelopmental disorders (NDDs).
  • Maternal inflammation during pregnancy is a risk factor for NDDs.
  • Gut microbiota significantly influences TRP metabolic pathways.

Purpose of the Study:

  • To investigate the association between TRP metabolite disturbance and neuropathological/behavioral abnormalities in offspring exposed to prenatal inflammation.
  • To explore the role of gut microbiota in TRP metabolism and its impact on neurodevelopment.

Main Methods:

  • Used juvenile female rats exposed prenatally to Poly I:C (an immune activator).
  • Assessed behavior (anxiety, social interaction, spatial memory), neuroinflammation (microglial activation in PFC), and TRP-kynurenine (KYN) pathway activity.
  • Analyzed gut microbial composition and intestinal TRP metabolism.

Main Results:

  • Prenatal Poly I:C exposure caused anxiety, impaired social interaction, and spatial memory deficits.
  • Observed sustained microglial activation, neuroinflammation in the PFC, and altered TRP-KYN pathway activity.
  • Found gut microbiota dysbiosis, reduced microbial diversity, and altered TRP metabolism, correlating with behavioral issues.

Conclusions:

  • Aberrant TRP metabolism linked to gut microbiota dysbiosis contributes to neuroinflammation and behavioral deficits after prenatal immune activation.
  • The gut-microbiota-TRP axis is a key mechanism underlying neurodevelopmental impairments.
  • Targeting this axis may offer therapeutic strategies for NDDs.
Abstract